Cell Matrix Inc.
This article was originally published in Start Up
Executive Summary
The enthusiasm of the founders of Cell Matrix, which was founded in late 1999 to pursue its own anti-angiogenesis approach to cancer, hasn't been dampened by the failures of its forebears. They believe the company has what competitors lack: a family of antibodies that is selective for angiogenesis.